Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0880220140520080681
Journal of Microbiology
2014 Volume.52 No. 8 p.681 ~ p.688
A potent Brucella abortus 2308 ¥Äery live vaccine allows for the differentiation between natural and vaccinated infection
Zhang Junbo

Yin Shuanghong
Guo Fei
Meng Ren
Chen Chuangfu
Zhang Hui
Li Zhiqiang
Fu Qiang
Shi Huijun
Hu Shengwei
Ni Wei
Li Tiansen
Zhang Ke
Abstract
Brucellosis is a globally distributed zoonotic disease that causes animal and human diseases. However, the current Brucella abortus vaccines (S19 and RB51) are deficient; they can cause abortion in pregnant animals. Moreover, when the vaccine S19 is used, tests cannot differentiate natural from vaccinated infection. Therefore, a safer and more potent vaccine is needed. A Brucella abortus 2308 ery promoter mutant (¥Äery) was constructed to overcome these drawbacks. The growth of the ¥Äery mutant was significantly attenuated in macrophages and mice and induced high protective immunity in mice. Moreover, ¥Äery induced an anti-Brucella-specific IgG (immunoglobulin G) response and stimulated the expression of interferon-gamma (INF-¥ã) and interleukin-4 (IL-4). Furthermore, the expression of EryA antigen allowed for the serological differentiation between natural and vaccinated infection in mice. These results indicate that the ¥Äery mutant is a potential attenuated live vaccine candidate against virulent Brucella abortus 2308 (S2308) infection.
KEYWORD
Brucella abortus 2308, ery promoter mutant, live attenuated vaccine, EryA
FullTexts / Linksout information
Listed journal information
MEDLINE ÇмúÁøÈïÀç´Ü(KCI) ´ëÇÑÀÇÇÐȸ ȸ¿ø